Journal article
Nicotine Replacement Combined with a Novel Compound (ProBAN) for Smoking Cessation: A Pilot Study
Abstract
BACKGROUND: Smoking cessation rates with available pharmacological therapies remain suboptimal. Anecdotal observations with a combination of sublingual pralidoxime and ipratropium (ProBAN) suggested that these agents in combination with nicotine gum improved quit rates.
OBJECTIVE: To determine whether ProBAN together with nicotine replacement improves quit rates compared with nicotine replacement alone.
Authors
Leigh R; Viner NM; Cox G; Balon JW; MC Wilson D; O’Shaughnessy D; Walker C; Brosky G; Sears MR
Journal
Canadian Respiratory Journal, Vol. 8, No. 1, pp. 21–26
Publisher
Wiley
Publication Date
January 2001
DOI
10.1155/2001/947097
ISSN
1198-2241